Phenescaline
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Phenescaline, also known as 3,5-dimethoxy-4-phenylethoxyphenethylamine, is a psychoactive drug of the phenethylamine and scaline families related to mescaline.[1] It is the derivative of mescaline in which the methoxy group at the 4 position has been replaced with a phenylethoxy group.[1] In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists phenescaline's dose as greater than 150 mg orally and its duration as unknown.[1] The effects of phenescaline have been reported to include threshold effects and a vague unreal feeling as if one had not had enough sleep.[1] The drug shows affinity for the serotonin 5-HT2A receptor (Ki = 59 nM).[2] The chemical synthesis of phenescaline has been described.[1] Phenescaline was first described in the literature by Shulgin in PiHKAL in 1991.[1]
- None
| Clinical data | |
|---|---|
| Other names | 3,5-Dimethoxy-4-phenylethoxyphenethylamine; 4-Phenylethoxy-3,5-dimethoxyphenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonin receptor modulator; Psychoactive drug |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H32NO3 |
| Molar mass | 310.458 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |